Zoccali, C. et al. The systemic nature of CKD. Nat. Rev. Nephrol. 13, 344–358 (2017).

Article  PubMed  Google Scholar 

Afkarian, M. et al. Kidney disease and increased mortality risk in type 2 diabetes. J. Am. Soc. Nephrol. 24, 302–308 (2013).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wan, E. Y. F. et al. Burden of CKD and cardiovascular disease on life expectancy and health service utilization: a cohort study of Hong Kong Chinese hypertensive patients. J. Am. Soc. Nephrol. 30, 1991–1999 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kalantar-Zadeh, K. et al. Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat. Rev. Nephrol. 18, 185–198 (2022).

Article  PubMed  Google Scholar 

Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112–S119 (1998).

Article  PubMed  CAS  Google Scholar 

Matsushita, K. et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat. Rev. Nephrol. 18, 696–707 (2022).

Article  PubMed  Google Scholar 

Modi, Z. J. et al. Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: an analysis of the US renal data system. JAMA Cardiol. 4, 353–362 (2019).

Article  PubMed  PubMed Central  Google Scholar 

NCD_Alliance. Home / WHY NCDs / NCDs / Chronic Kidney Disease. ncdalliance.org https://ncdalliance.org/why-ncds/ncds/chronic-kidney-disease (2017).

Rosner, M. H. et al. Classification of uremic toxins and their role in kidney failure. Clin. J. Am. Soc. Nephrol. 16, 1918–1928 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jaksch On uræmia. Chic. Med. J. 18, 396–397 (1861).

PubMed  PubMed Central  CAS  Google Scholar 

Balestri, P. L., Biagini, M., Rindi, P. & Giovannetti, S. Uremic toxins. Arch. Intern. Med. 126, 843–845 (1970).

Article  PubMed  CAS  Google Scholar 

Desi, I., Feher, E., Szold, A., Weisz, P. & Kadas, T. [Determination of toxicity of uremic blood treated with ion exchange resins]. Z. Gesamte Inn. Med. 12, 1127–1130 (1957).

PubMed  CAS  Google Scholar 

Babb, A. L., Ahmad, S., Bergström, J. & Scribner, B. H. The middle molecule hypothesis in perspective. Am. J. Kidney Dis. 1, 46–50 (1981).

Article  PubMed  CAS  Google Scholar 

Thomas, M., Moriyama, K. & Ledebo, I. AN69: evolution of the world’s first high permeability membrane. Contrib. Nephrol. 173, 119–129 (2011).

Article  PubMed  CAS  Google Scholar 

Gejyo, F. et al. A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem. Biophys. Res. Commun. 129, 701–706 (1985).

Article  PubMed  CAS  Google Scholar 

Kasanen, A. Serum indican and endogenous indican clearance in renal insufficiency. Ann. Med. Intern. Fenn. Suppl. 46, 1–71 (1957).

PubMed  CAS  Google Scholar 

Niwa, T. & Ise, M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J. Lab. Clin. Med. 124, 96–104 (1994).

PubMed  CAS  Google Scholar 

Vanholder, R., Glorieux, G., De Smet, R. & Lameire, N. New insights in uremic toxins. Kidney Int. Suppl. 63, S6–S10.

Vanholder, R. et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63, 1934–1943 (2003).

Article  PubMed  CAS  Google Scholar 

Duranton, F. et al. Normal and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol. 23, 1258–1270 (2012).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hocher, B. & Adamski, J. Metabolomics for clinical use and research in chronic kidney disease. Nat. Rev. Nephrol. 13, 269–284 (2017).

Article  PubMed  CAS  Google Scholar 

Vanholder, R. et al. Metabolomics to identify unclassified uremic toxins: a comprehensive literature review. Kidney Med. 7, 100955 (2025).

Article  PubMed  Google Scholar 

Luo, S. et al. Serum metabolomic alterations associated with proteinuria in CKD. Clin. J. Am. Soc. Nephrol. 14, 342–353 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Titan, S. M. et al. Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: results from the Progredir cohort. PLoS ONE 14, e0213764 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 (2011).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wen, D. et al. Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study. JCI insight 7, e161696 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Lee, A. M. et al. Circulating metabolomic associations with neurocognitive outcomes in pediatric CKD. Clin. J. Am. Soc. Nephrol. 19, 13–25 (2024).

Article  PubMed  CAS  Google Scholar 

Kikuchi, K. et al. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat. Commun. 10, 1835 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Gajjala, P. R., Fliser, D., Speer, T., Jankowski, V. & Jankowski, J. Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. Nephrol. Dial. Transplant. 30, 1814–1824 (2015).

Article  PubMed  CAS  Google Scholar 

Noels, H. et al. Post-translational modifications in kidney diseases and associated cardiovascular risk. Nat. Rev. Nephrol. 20, 495–512 (2024).

Article  PubMed  CAS  Google Scholar 

Meijers, B., Glorieux, G., Poesen, R. & Bakker, S. J. Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go? Semin. Nephrol. 34, 228–243 (2014).

Article  PubMed  CAS  Google Scholar 

Mishima, E. et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int. 92, 634–645 (2017).

Article  PubMed  CAS  Google Scholar 

Evenepoel, P, Meijers, B. K., Bammens, B. R. & Verbeke, K. Uremic toxins originating from colonic microbial metabolism. Kidney Int. 76 (Supp. 114), S12–S19 (2009).

Article  Google Scholar 

Wikoff, W. R., Nagle, M. A., Kouznetsova, V. L., Tsigelny, I. F. & Nigam, S. K. Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J. Proteome Res. 10, 2842–2851 (2011).

Article  PubMed  PubMed Central  CAS